Quadrature Capital’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,951
Closed -$221K 2080
2026
Q1
$221K Buy
+2,951
New +$242K ﹤0.01% 1085
2025
Q1
Sell
-3,446
Closed -$306K 1498
2024
Q4
$306K Buy
3,446
+946
+38% +$84.3K 0.01% 727
2024
Q3
$212K Sell
2,500
-2,388
-49% -$212K ﹤0.01% 765
2024
Q2
$452K Buy
+4,888
New +$494K 0.01% 689
2022
Q3
Sell
-2,490
Closed -$271K 1105
2022
Q2
$271K Sell
2,490
-1,285
-34% -$136K 0.01% 558
2022
Q1
$376K Sell
3,775
-4,582
-55% -$437K 0.02% 462
2021
Q4
$798K Buy
+8,357
New +$838K 0.04% 270
2019
Q2
Sell
-3,310
Closed -$348K 674
2019
Q1
$348K Buy
+3,310
New +$356K 0.03% 382

Other funds holding USPH

Quadrature Capital's USPH Position: Q2 2026 in Review

Quadrature Capital sold out of US Physical Therapy (USPH) in Q2 2026, closing a stake of 2,951 shares — an estimated $221K sold.

Quadrature Capital first reported a position in USPH in Q1 2019 and held it in 8 quarters. The position peaked at $798K in Q4 2021. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.

  • Quadrature Capital reported no remaining US Physical Therapy position as of Q2 2026 after selling out during the quarter.
  • Quadrature Capital sold 2,951 US Physical Therapy shares in Q2 2026, an estimated $221K.
  • Quadrature Capital first reported a position in US Physical Therapy in Q1 2019 and held it in 8 quarters.
  • Quadrature Capital's US Physical Therapy position peaked at $798K in Q4 2021.
  • 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.